You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Triple-negative metastatic breast cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Triple Negative Breast Cancer, Metastatic Breast Cancer Trial (Sacituzumab govitecan)

Not yet recruiting
  • Triple Negative Breast Cancer
  • Metastatic Breast Cancer
  • Sacituzumab govitecan
  • (no location specified)
Jan 23, 2023

Breast Cancer Trial in Boston (Abemaciclib)

Terminated
Has Results
  • Breast Cancer
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Oct 3, 2022

Eribulin-Based Regimen Versus Other Chemotherpy in

Active, not recruiting
  • Breast Cancer
  • Eribulin-Based Regimen
  • +2 more
  • Fuzhou, Fujian, China
    Fujian Cancer Hospital
Jul 18, 2023

Breast Cancer, Invasive Breast Cancer, Unresectable Breast Carcinoma Trial in Boston (Onvansertib, Paclitaxel)

Recruiting
  • Breast Cancer
  • +9 more
  • Boston, Massachusetts
  • +2 more
Oct 25, 2022

Estrogen Receptor Negative, HER2/Neu Negative, Progesterone Receptor-negative Trial in Duarte, Rancho Cucamonga, South Pasadena

Completed
Has Results
  • Estrogen Receptor Negative
  • +4 more
  • Duarte, California
  • +2 more
Jun 6, 2022

Immunotherapy-related CRP Kinetics in Early and Metastatic

Recruiting
  • TNBC - Triple-Negative Breast Cancer
    • Tuebingen, Germany
      Department of Women's Health
    Jun 13, 2023

    Metastatic Triple-Negative Breast Cancer Trial in Charlotte (Trilaciclib, Pembrolizumab, Gemcitabine)

    Not yet recruiting
    • Metastatic Triple-Negative Breast Cancer
    • Charlotte, North Carolina
      Levine Cancer Institute
    Aug 31, 2023

    TNBC - Triple-Negative Breast Cancer Trial in Wuhan (Utidelone, Tirelizumab, Bevacizumab)

    Recruiting
    • TNBC - Triple-Negative Breast Cancer
    • Wuhan, Hubei, China
      Tongji Hospital Affiliated of Tongji Medical College Huazhong Un
    Nov 5, 2023

    Metastatic Breast Cancer, Triple Negative Breast Cancer, Estrogen-receptor-low Breast Cancer Trial in Carmel, Indianapolis

    Not yet recruiting
    • Metastatic Breast Cancer
    • +2 more
    • Carmel, Indiana
    • +2 more
    Apr 27, 2023

    Triple Negative Breast Cancer, Metastatic Breast Cancer, Mutation Trial in Shanghai (Everolimus, Investigator's Choice of

    Not yet recruiting
    • Triple Negative Breast Cancer
    • +2 more
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Jul 25, 2023

    Breast Tumors Trial in Hangzhou (Sindilimab, Nab-paclitaxel, Lenvatinib)

    Not yet recruiting
    • Breast Neoplasms
    • Hangzhou, Zhejiang, China
      ZhejiangCH
    Nov 17, 2023

    Triple-Negative Breast Cancer Trial in Shanghai (Trastuzumab Deruxtecan)

    Not yet recruiting
    • Triple-Negative Breast Cancer
    • Trastuzumab Deruxtecan
    • Shanghai, Shanghai, China
      Breast cancer institute of Fudan University Cancer Hospital
    Jul 12, 2023

    Triple-Negative Breast Cancer Trial in Shanghai (VEGFR, nab-paclitaxel, Eribulin Mesylate/Vinorelbine/Capecitabine/Carboplatin)

    Recruiting
    • Triple-Negative Breast Cancer
    • Shanghai, Shanghai, China
      Breast cancer institute of Fudan University Cancer Hospital
    Mar 28, 2023

    Molecular PD-L1 PET/CT Imaging With 89Zr-atezolizumab in

    Not yet recruiting
    • Metastatic Triple-Negative Breast Carcinoma
    • 89Zr-atezolizumab PET/CT
    • (no location specified)
    Feb 22, 2023

    Metastatic Triple-negative Breast Cancer Trial in Wuhan (Surufatinib, Tislelizumab)

    Not yet recruiting
    • Metastatic Triple-negative Breast Cancer
    • Wuhan, Hubei, China
      Tongji Hospital Affiliated of Tongji Medical College Huazhong Un
    Feb 27, 2023

    TNBC - Triple-Negative Breast Cancer Trial (Alkaline Glucosodiene Molecules)

    Not yet recruiting
    • TNBC - Triple-Negative Breast Cancer
    • Alkaline Glucosodiene Molecules
    • (no location specified)
    Jul 14, 2023

    Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma Trial in Duarte (drug, biological, other)

    Not yet recruiting
    • Anatomic Stage IV Breast Cancer AJCC v8
    • Metastatic Triple-Negative Breast Carcinoma
    • Los Angeles, California
      Cedars-Sinai Medical Center
    Jan 6, 2023

    Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma

    Not yet recruiting
    • Anatomic Stage III Breast Cancer AJCC v8
    • +4 more
    • Biopsy
    • +5 more
    • Buffalo, New York
      Roswell Park Cancer Institute
    Feb 14, 2023

    Triple Negative Breast Cancer Trial in Guangzhou (Chidamide combined with Zimberelimab)

    Recruiting
    • Triple Negative Breast Cancer
    • Chidamide combined with Zimberelimab
    • Guangzhou, Guangdong, China
      Sun Yat-sen University, Cancer Center
    Nov 20, 2022

    Breast Cancer Trial (RO7247669, Pembrolizumab, Nab-Paclitaxel)

    Not yet recruiting
    • Breast Cancer
    • (no location specified)
    May 2, 2023

    Breast Cancer Female, Triple Negative Breast Cancer Trial (quercetin, EGCG, metformin , zinc)

    Not yet recruiting
    • Breast Cancer Female
    • Triple Negative Breast Cancer
    • quercetin, EGCG, metformin , zinc
    • (no location specified)
    Dec 23, 2022

    Metastatic Triple-Negative Breast Carcinoma, Breast Cancer Trial in Dallas (Neratinib Oral Tablet, Ruxolitinib Oral Tablet)

    Not yet recruiting
    • Metastatic Triple-Negative Breast Carcinoma
    • Breast Cancer
    • Neratinib Oral Tablet
    • Ruxolitinib Oral Tablet
    • Dallas, Texas
      Baylor University Medical Center, Baylor Charles A Sammons Cance
    Aug 22, 2023

    Metastatic Triple-negative Breast Cancer, Locally Advanced Triple-negative Breast Cancer Trial in Changsha, Xiangyang (AK117,

    Recruiting
    • Metastatic Triple-negative Breast Cancer
    • Locally Advanced Triple-negative Breast Cancer
    • Changsha, China
    • +1 more
    Sep 8, 2022

    Triple Negative Breast Cancer Trial in Guangzhou (Capecitabine, Tucidinostat)

    Recruiting
    • Triple Negative Breast Cancer
    • Guangzhou, Guangdong, China
      Sun-yat sen university cancer center
    Nov 1, 2022

    Triple Negative Breast Cancer, Metastatic Breast Cancer Trial in Boston (Pembrolizumab, PVX-410)

    Active, not recruiting
    • Triple Negative Breast Cancer
    • Metastatic Breast Cancer
    • Boston, Massachusetts
    • +2 more
    Dec 21, 2022